UNSPSC 51143212: Lobeline sulfate

This classification denotes a nicotinic agonist with the molecular formula 2C22H27NO2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4CJ480V2HP, chemically known as lobeline, sulfate (2:1) (salt) but more generally known as lobeline sulfate, which bears US NIH Compound Identifier 120636. European Medicines Agency schedules Lobeline sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02962MIG.

Most nations, for tariff and trade purposes, schedule lobeline sulfate under HS 29399900 and SITC 54149. As of Q4 2014, LOBELINE SULFATE remains US FDA's Preferred Term for this commodity. SMILES: CN1[C@@H](CCC[C@@H]1CC(=O)C2CCCCC2)C[C@@H](C3CCCCC3)O.CN1[C@@H](CCC[C@@H]1CC(=O)C2CCCCC2)C[C@@H](C3CCCCC3)O.OS(=O)(=O)O.

UNSPSC 51143212 Loboline sulfate is a Commodity code that state and local governments have tagged to procurements involving naloxone, drug deactivation systems, and pharmacy benefit program design, though the recent opportunities show limited direct relevance to the nominal chemical product. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; vendors must submit bids electronically, include shipping and delivery costs, and comply with drug-free workplace and E-Verify requirements. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, requesting information about vendors' experience with direct contracting for self-insured employers and health plans, negotiated net pricing models, and outcomes-based agreements. Both opportunities originate from state and local health and social-service agencies rather than traditional pharmaceutical procurement offices, reflecting the code's use in community health and pharmacy program contexts.

The recent opportunities cluster in Florida and Texas, with Seminole County's naloxone procurement representing a fixed-term, quota-based annual buy and the Texas HHS RFI functioning as exploratory market research prior to formal solicitation. The Seminole County contract carries a two-year initial term with a one-year renewal option and requires compliance with federal regulations potentially tied to FEMA funding, including the Clean Air Act and Federal Water Pollution Control Act. The Texas RFI contains no award values, set-asides, or binding timelines, as it is designed to gather foundational vendor information before the state issues a formal RFP. The code shows sparse and geographically limited recent activity, and the opportunities posted do not clearly align with the chemical substance the code nominally describes, suggesting either a tagging mismatch or a broad interpretation of the code to cover pharmacy-related procurement more generally.